Related Experiment Video
Updated: Jun 13, 2026
11:59
Competitive Genomic Screens of Barcoded Yeast Libraries
Published on: August 11, 2011
High-content, image-based screening for drug targets in yeast
Shinsuke Ohnuki1, Satomi Oka, Satoru Nogami
1Department of Integrated Biosciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Chiba, Japan.
Plos One
|April 27, 2010
Summary
This study introduces a new method combining genetic screening and high-content imaging in yeast to identify drug targets. The approach successfully pinpointed known drug targets and related pathways by analyzing cellular morphology changes.
Area of Science:
- Cell biology
- Genetics
- Drug discovery
Background:
- Elucidating drug mechanisms and targets is crucial for drug discovery and development.
- High-content imaging enables simultaneous analysis of multiple cellular events.
- A novel strategy is needed to combine genetic screening and imaging for target identification.
Purpose of the Study:
- To develop and demonstrate a novel strategy for identifying drug targets.
- To combine genetic screening with high-content imaging in yeast.
- To infer cellular functions affected by candidate drugs based on morphologic changes.
Main Methods:
- Utilized a yeast model system for genetic screening.
- Employed high-content imaging to capture cellular morphologic changes.
- Compared compound-induced morphologic changes with yeast mutant phenotypes to infer function.
Main Results:
- Successfully identified previously known target genes for four well-characterized reagents.
- Discovered additional genes involved in functionally related cellular pathways.
- Demonstrated the method's efficacy in identifying drug targets through morphologic phenotypes.
Conclusions:
- This study presents the first genetic high-content assay for drug target identification.
- The method leverages morphologic phenotypes of a reference mutant panel.
- This approach offers a powerful tool for understanding drug action and discovering new targets.
